Cornell University

Newly-Hatched Great Horned Owlets Are Live on Camera at the Lady Bird Johnson Wildflower Center

Retrieved on: 
Tuesday, April 9, 2024
Cornell Lab of Ornithology, Communication, Lady Bird, Cornell University, Marketing, Dasylirion, Lady Bird Johnson, Poultry farming

Austin, Texas, April 09, 2024 (GLOBE NEWSWIRE) -- Austin, TX– In April, the Lady Bird Johnson Wildflower Center and Cornell Lab of Ornithology collaborated to launch a live bird camera featuring the Center’s beloved great horned owl, Athena , in her nesting site just beyond the entrance to the Center’s gardens.

Key Points: 
  • Austin, Texas, April 09, 2024 (GLOBE NEWSWIRE) -- Austin, TX– In April, the Lady Bird Johnson Wildflower Center and Cornell Lab of Ornithology collaborated to launch a live bird camera featuring the Center’s beloved great horned owl, Athena , in her nesting site just beyond the entrance to the Center’s gardens.
  • Now, the world can watch along live as the two tiny owlets grow and fledge the nest over the coming several weeks.
  • For more information about visiting Athena at the Lady Bird Johnson Wildflower Center, visit the website here .
  • For press inquiries, contact Scott Simons , Director of Marketing and Communications at the Wildflower Center.

Scot Sellers to Be Named Chairman of the Board of Howard Hughes Holdings Inc. at Company’s Upcoming Annual Meeting

Retrieved on: 
Thursday, April 4, 2024
Irvine Company, Growth, Blackstone Inc., Howard Hughes, Cornell University, Mergers and acquisitions, MPC, Acquisition, GGP Inc., City, HHH, The, Partner, Collection, Pershing Square Capital Management, Mergers & Acquisitions, Ackman

THE WOODLANDS, Texas, April 04, 2024 (GLOBE NEWSWIRE) -- Howard Hughes Holdings Inc. (NYSE: HHH) announced today that long-time Howard Hughes board member Scot Sellers will be named Chairman of its Board of Directors at HHH’s upcoming annual meeting. Sellers will succeed Pershing Square Capital Management, L.P. (“Pershing Square”) Founder and CEO Bill Ackman, who will be retiring from the HHH board after serving as its chairman since founding Howard Hughes in 2010. Pershing Square Partner Ben Hakim is being nominated for the Howard Hughes board to replace Ackman. Pershing Square intends to remain a major, long-term shareholder of HHH.

Key Points: 
  • Long-time HHH Board Member and former Archstone CEO to succeed Bill Ackman as Board Chairman;
    THE WOODLANDS, Texas, April 04, 2024 (GLOBE NEWSWIRE) -- Howard Hughes Holdings Inc. (NYSE: HHH) announced today that long-time Howard Hughes board member Scot Sellers will be named Chairman of its Board of Directors at HHH’s upcoming annual meeting.
  • Pershing Square Partner Ben Hakim is being nominated for the Howard Hughes board to replace Ackman.
  • Sellers has served on the Board of Directors of Howard Hughes since the company’s inception.
  • Sellers currently serves on the board of The Irvine Company and is Chairman of the Board of Maui Land & Pineapple Company.

EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists

Retrieved on: 
Tuesday, April 2, 2024
Patient, MIB, ARI, Therapy, AAO, Research, Surgeon, Thomas Jefferson University, German Research Foundation, Chairperson, American Diabetes Association, Macular degeneration, SAB, FACS, Food, Cornell University, Empire, University, Castle Connolly Medical, Laborie (company), Publication, Emerita, AMD, FDA, Cochrane (organisation), Moorfields Eye Hospital, American Academy, Most, Consultant, Physician, Royal college, Diabetic retinopathy, Commander, Pharmaceutical industry

WATERTOWN, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, today announced the appointment of leading global ophthalmologists to its Scientific Advisory Board (SAB), co-chaired by Carl Regillo M.D., FACS, Chief of the Retina Service at Wills Eye Hospital and Charles Wykoff, M.D., Ph.D., Director of Research of Retina Consultants of Texas. The SAB additions include Usha Chakravarthy, M.B.B.S., Ph.D.; Allen Ho, M.D. FACS FASRS, and Frank Holz, M.D., F.E.B.O., F.A.R.V.O. These three world-renowned retinal specialists will support advancement of the Company’s global clinical strategy ahead of the anticipated initiation of its Phase 3 pivotal trials in wet age-related macular degeneration (wet AMD) in the second half of this year. Additionally, the Company announced that the U.S. Food and Drug Administration (FDA) has conditionally accepted the trade name, DURAVYUTM (vorolanib intravitreal insert) for the Company’s lead product candidate, EYP-1901.

Key Points: 
  • “The SAB’s strategic counsel, global expertise, and scientific knowledge will be incredibly valuable during this critical time in EyePoint’s growth and expansion.
  • Dr. Chakravarthy has authored or co-authored over 400 publications, and she is invited to lecture in the UK and abroad.
  • FACS FASRS is Attending Surgeon, Director of Retina Research and Co-Director of the Retina Service of Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University.
  • He is a Board Member of the German Ophthalmological Society, and of the Club Jules Gonin and is past president of EURETINA.

GSI Technology Announces Production Release of Two Gemini-I® APU Servers

Retrieved on: 
Tuesday, April 2, 2024
GSI, Database, APU, NAU, Drug discovery, Application layer, HPC, DNA, Artificial intelligence, Cornell University, Northern Arizona University, University of Arizona, Associative property, Gemini, A100, Facial recognition, Video game

SUNNYVALE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- GSI Technology, Inc. (Nasdaq: GSIT), the inventor of the Associative Processing Unit (APU), a paradigm shift in artificial intelligence (AI) and high-performance compute (HPC) processing providing true compute-in-memory technology, today announced the release in production of two high capacity, low power server products.

Key Points: 
  • SUNNYVALE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- GSI Technology, Inc. (Nasdaq: GSIT), the inventor of the Associative Processing Unit (APU), a paradigm shift in artificial intelligence (AI) and high-performance compute (HPC) processing providing true compute-in-memory technology, today announced the release in production of two high capacity, low power server products.
  • The Leda-E and Leda-S boards incorporate the Gemini-I® APU, capable of 1.2 POPs at 80W and 800 TOPs at 40W, respectively.
  • GSI's true compute-in-memory technology has proven differentiated capabilities in large (billion item) database search and high-performance compute applications, such as facial recognition, drug discovery, Opensearch, and object detection and re-identification.
  • Server systems based on GSI’s production Gemini-I APU chip come pre-bundled with an application development compiler and can be further customized with Real-Time Fast Back Projection software or Fast Vector Search support.

SIAM Announces Class of 2024 Fellows

Retrieved on: 
Thursday, March 28, 2024
CNRS, Editorial, Mathematics, Sorbonne University, Climate change, Algorithm, Masaryk University, Utrecht University, Data science, State university system, Cornell University, Systems theory, University of Utah, City University, University of Massachusetts, Research, University of British Columbia, Platelet, University, Software, IBM, University of Cambridge, University of Exeter, Statistics, Industrial, Rutgers University, University of Zurich, University of Waterloo, Stanford University, Virginia Tech, Probability, Lehigh University, Engineering, Lawrence Berkeley National Laboratory, Information technology

Philadelphia, PA, March 28, 2024 (GLOBE NEWSWIRE) -- Society for Industrial and Applied Mathematics (SIAM) is pleased to announce the 2024 Class of SIAM Fellows.

Key Points: 
  • Philadelphia, PA, March 28, 2024 (GLOBE NEWSWIRE) -- Society for Industrial and Applied Mathematics (SIAM) is pleased to announce the 2024 Class of SIAM Fellows.
  • Through their various contributions, SIAM Fellows form a crucial group of individuals helping to advance the fields of applied mathematics, computational science, and data science.
  • Hans De Sterck, University of Waterloo, is being recognized for contributions to scientific computing methods including multilevel and nonlinear solvers, and for exemplary scientific leadership and service to SIAM.
  • Fred S. Roberts, Rutgers University, is being recognized for distinguished research in discrete mathematics, leadership of major research centers, and service to SIAM.

Orchard Robotics Raises $3.8M led by General Catalyst to Build Robots & AI that Power Precision Crop Management

Retrieved on: 
Thursday, March 28, 2024
Automation, Farmer, Farm, Partnership, Cornell University, Dwight (The Walking Dead), Robotics, AI, Food, Thiel Fellowship, Fruit, Tree, Orchard, Agriculture

SEATTLE, March 28, 2024 (GLOBE NEWSWIRE) -- Orchard Robotics, the company enabling precision crop management with robots and AI, announced today their $3.8M raise, across a seed round led by General Catalyst, and a pre-seed led by Contrary.

Key Points: 
  • SEATTLE, March 28, 2024 (GLOBE NEWSWIRE) -- Orchard Robotics, the company enabling precision crop management with robots and AI, announced today their $3.8M raise, across a seed round led by General Catalyst, and a pre-seed led by Contrary.
  • Orchards can have millions of trees, growing hundreds of millions of fruit, spanning thousands of acres.
  • And every tree is unique, needing specific inputs, treatments, and care all season long in order to produce the best fruit.
  • “Our mission at Orchard Robotics is to help farmers produce more food for the world, more profitability, efficiently, and sustainably.

One Biosciences Welcomes Dr. Scott Braunstein and Dr. Vincent Miller to its Board of Directors

Retrieved on: 
Wednesday, March 27, 2024
Constellation, Single-cell analysis, Lung cancer, EGFR, Health, Biotechnology, Rachel Haurwitz, New Jersey Medical School, Foundation Medicine, Cornell University, University, Knowledge, American Cancer Society, Research, Esperion Therapeutics, Cancer, A.I, Medicine, Summit Health, Esperies, Therapy, Drug development, Partner, MorphoSys, JPMorgan Chase, Thomas Jefferson University Hospital

to identify a new generation of precision medicine targets and develop new treatments, today announced the appointments of Dr. Scott Braunstein, and Dr. Vincent Miller, to its Board of Directors.

Key Points: 
  • to identify a new generation of precision medicine targets and develop new treatments, today announced the appointments of Dr. Scott Braunstein, and Dr. Vincent Miller, to its Board of Directors.
  • Our proprietary discovery engine has identified its first promising targets, and we are preparing to start drug development activities in 2025.
  • Bolstering our Board with such seasoned leaders will be a key factor to success.”
    Dr. Scott Braunstein brings over 30 years of knowledge and experience gained in the biotechnology, pharmaceutical, and biotech portfolio management industries.
  • Dr. Braunstein is currently on the board at Trevena and Caribou Biosciences.

AvidXchange Announces Board Additions and Transitions

Retrieved on: 
Tuesday, March 26, 2024
Opus, Constellation, UnitedHealth Group, Health, AlixPartners, Sale, Engineering, Oni, McKinsey & Company, Audit, Private equity, Risk, TeamHealth, Bain Capital Ventures, Software, KKR, Compensated emancipation, AP, CDPQ, Business administration, Cornell University, Harvard Business School, SAP, University, IPO, Royal, Risk management, Culture, PKS, Growth, Allied Universal, MBA, SAP AG, Event management software, Partner, AJ, Tech, Management

CHARLOTTE, N.C., March 26, 2024 (GLOBE NEWSWIRE) -- AvidXchange Holdings, Inc. (Nasdaq: AVDX), a leading provider of accounts payable (AP) automation software and payment solutions for middle market businesses and their suppliers, today announced the appointment of two new Board members – Oni Chukwu and Arthur J. (“A.J.”) Rubado. Mr. Chukwu was elected by the Board to serve as a Class I director of the Company effective upon the resignation of Ms. Murdock. Mr. Rubado was elected by the Board to serve as Class III director of the Company effective upon the resignation of Mr. Harris. Messrs. Chukwu’s and Rubado’s terms will expire at the annual meeting of the Company’s stockholders to be held in 2025 and 2024, respectively. The appointments maintain the number of directors at nine, eight of whom are independent.

Key Points: 
  • Mr. Chukwu was elected by the Board to serve as a Class I director of the Company effective upon the resignation of Ms. Murdock.
  • Mr. Rubado was elected by the Board to serve as Class III director of the Company effective upon the resignation of Mr. Harris.
  • I wish them all the best,” stated Michael S. Praeger, Chairman and Chief Executive of AvidXchange Holdings, Inc.
    Concurrent with the aforementioned additions, AvidXchange announced that Matthew Harris and Wendy Murdock have resigned from the Board and any committees on which they served, effective March 21, 2024.
  • Both joined the AvidXchange Board, prior to the Company’s IPO, in connection with the Company’s institutional capital raises.

Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors

Retrieved on: 
Tuesday, April 9, 2024
Biotechnology, Pharmaceutical, Health, Clinical Trials, Neuroscience, Juno Therapeutics, Genentech, Cornell University, Heredity, Patient, Carmustine, Acquisition, Allergy, Senior, Research and development, Therapy, Drug development, Rituximab, Management

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced the appointment of Sunil Agarwal, M.D., to its Board of Directors.

Key Points: 
  • Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced the appointment of Sunil Agarwal, M.D., to its Board of Directors.
  • Dr. Agarwal has more than 20 years of biotechnology research, development, and commercialization experience.
  • “It is a pleasure to welcome Sunil to our Board of Directors,” said Jill C. Milne, Ph.D., Chief Executive Officer at Astria Therapeutics.
  • “STAR-0215 has the potential to significantly improve the lives of patients and I look forward to contributing to its progress at this exciting time.”
    Dr. Agarwal currently serves on the Board of Directors of Arvinas and was previously a Board member of Calithera Biosciences, MyoKardia, and Vitrisa Therapeutics.

RAYMOND ANNOUNCES 2024 FUNDING RECIPIENTS FOR UNIVERSITY RESEARCH PROGRAM

Retrieved on: 
Thursday, March 21, 2024
University, Dean (education), Cornell University, Research, Engineering, Pharmaceutical industry

Greene, N.Y., March 21, 2024 (GLOBE NEWSWIRE) -- The Raymond Corporation has selected three research proposals to receive funding through The Raymond Corporation University Research Program .

Key Points: 
  • Greene, N.Y., March 21, 2024 (GLOBE NEWSWIRE) -- The Raymond Corporation has selected three research proposals to receive funding through The Raymond Corporation University Research Program .
  • The research proposals selected for funding are:
    Proposal Author: Associate Dean and Professor Silvia Ferrari, Cornell University
    The University Research Program helps to drive the next generation of technology for the supply chain, logistics and material handling industries.
  • The University Research Program has funded 18 projects from 20 leading universities across the country, totaling more than $5 million in funding.
  • To learn more about the University Research Program, including information on previously funded projects and how to apply, visit www.universityresearchprogram.com or contact Steve Medwin, Raymond university ambassador, at [email protected] .